Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

3 Stocks Near 52-Week Highs Worth Selling: Lumber Liquidators Holdings Inc (LL) and More

Page 1 of 2

A January U.S. budget surplus and more positive housing data are all that was needed to push the broader market higher yet again this week. For skeptics like me, that’s an opportunity to see whether companies have earned their current valuations.

Keep in mind that some companies deserve their current valuations. Flooring specialist Lumber Liquidators Holdings Inc (NYSE:LL) might seem a bit pricey on the surface, but its double-digit same-store sales increases driven by higher customer traffic and its revamped advertising campaign could be just the beginning. Let’s also not forget that Lumber Liquidators’ CEO, Robert Lynch, was voted CEO of the year by our Motley Fool community.

Still, other companies might deserve a kick in the pants. Here’s a look at three companies that could be worth selling.

Lumber Liquidators Holdings Inc (NYSE:LL)Check those expectations
Since it often pays to think ahead, I can completely understand why investors share a lot of optimism surrounding Medidata Solutions Inc (NASDAQ:MDSO), a cloud technology software provider that helps drugmakers manage their clinical data. Medidata actually hooked a gigantic client in Sanofi in October when the company chose Medidata’s cloud software to store all of its research and development data. This is a company where the concept makes a lot of sense five years from now, but I simply don’t see enough demand in the near term to support its current valuation.

Medidata’s third-quarter results demonstrated steady sales growth of 21%; however, net income fell 46% and adjusted EPS missed expectations by $0.07. The company’s profit guidance for the upcoming quarter, which it’s scheduled to report next week, was also light at the time. We’re seeing more and more cases in which cloud management companies are forgoing bottom-line profits in favor of expansion, which results in higher expenses and smaller margins. That’s a formula that’ll work for a short time, but I doubt it’ll support Medidata’s forward P/E, which is currently north of 40. Investors should check their expectations with Medidata and walk away while they have the chance.

Where’s the beef?
I really have nothing against fast-food restaurant Jack in the Box Inc. (NASDAQ:JACK) as I feel it’s done a wonderful job of emulating McDonald’s Corporation (NYSE:MCD) by remodeling its restaurants and revitalizing its menu with healthier food options; but even the highest-quality restaurants stumble now and then.

McDonald’s has run into trouble lately overseas with decreased customer traffic in Europe and Asia, as well as pricing pressure on its food items domestically. Jack in the Box and McDonald’s share many similarities in that they’d both like to raise prices to accommodate higher food costs, but doing so, especially on their value menu items, could alienate some of their faithful customers. Similarly, the removal of the payroll tax holiday is going to leave the average taxpayer with $1,000 less in their pocket this year. That could dissuade consumers even further from eating out at even the cheapest fast-food establishments, like McDonald’s and Jack in the Box.

One prime difference between the two is that McDonald’s at least has its own signature coffee blend whereas Jack in the Box doesn’t. Unfortunately for Jack in the Box, its commercial figure (“Jack”) and not its food is the most identifying factor of the company. With Qdoba sales dramatically lagging behind Chipotle Mexican Grill, Inc. (NYSE:CMG), food costs rising, and the company valued at a spendy 20 times this year’s profit, I’d suggest putting these patties back in the freezer for the time being.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!